Diadema Partners »

Rocket Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $110k 31k 3.58

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Rocket Pharmaceuticals

Rtw Investments
BlackRock
Citigroup
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Maverick Capital
Newtyn Management
Nuveen
Millennium Management
AQR Capital Management
Marshall Wace
Geode Capital Management
D. E. Shaw & Co
Monaco Asset Management SAM

View all funds holding Rocket Pharmaceuticals